The increase in FSH and LH releasing that occurs following menopause has been associated with several deleterious biological effects, thereby promoting an increased risk for bone loss, obesity, CVD and cancer [19–21]. Here, BRD2 is linked to obesity due to melanocortin 4 receptor deficiency.